Market closed
Amedisys/AMED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Amedisys
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Ticker
AMED
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
19,000
Website
Amedisys Metrics
BasicAdvanced
$3.2B
Market cap
34.63
P/E ratio
$2.81
EPS
0.79
Beta
-
Dividend rate
Price and volume
Market cap
$3.2B
Beta
0.79
52-week high
$98.95
52-week low
$89.55
Average daily volume
343K
Financial strength
Current ratio
1.158
Quick ratio
1.056
Long term debt to equity
34.817
Total debt to equity
40.262
Interest coverage (TTM)
6.48%
Management effectiveness
Return on assets (TTM)
6.38%
Return on equity (TTM)
8.20%
Valuation
Price to earnings (TTM)
34.632
Price to revenue (TTM)
1.387
Price to book
2.83
Price to tangible book (TTM)
-14.45
Price to free cash flow (TTM)
35.891
Growth
Revenue change (TTM)
2.70%
Earnings per share change (TTM)
3,875.49%
3-year revenue growth (CAGR)
1.40%
3-year earnings per share growth (CAGR)
-27.77%
What the Analysts think about Amedisys
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Amedisys stock.
Amedisys Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Amedisys Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Amedisys News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Amedisys stock?
Amedisys (AMED) has a market cap of $3.2B as of October 26, 2024.
What is the P/E ratio for Amedisys stock?
The price to earnings (P/E) ratio for Amedisys (AMED) stock is 34.63 as of October 26, 2024.
Does Amedisys stock pay dividends?
No, Amedisys (AMED) stock does not pay dividends to its shareholders as of October 26, 2024.
When is the next Amedisys dividend payment date?
Amedisys (AMED) stock does not pay dividends to its shareholders.
What is the beta indicator for Amedisys?
Amedisys (AMED) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.